These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1516267)
1. Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro. Sodhi A; Suresh A Clin Exp Immunol; 1992 Sep; 89(3):502-8. PubMed ID: 1516267 [TBL] [Abstract][Full Text] [Related]
2. L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Keller R; Geiges M; Keist R Cancer Res; 1990 Mar; 50(5):1421-5. PubMed ID: 2302707 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. Anthony LS; Morrissey PJ; Nano FE J Immunol; 1992 Mar; 148(6):1829-34. PubMed ID: 1541823 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor. Keller R; Keist R; Wechsler A; Leist TP; van der Meide PH Int J Cancer; 1990 Oct; 46(4):682-6. PubMed ID: 2120138 [TBL] [Abstract][Full Text] [Related]
5. In vitro activation of rGM-CSF derived bone marrow macrophages by cisplatin and lipopolysaccharide. Sodhi A; Suresh A; Singh SM Immunol Cell Biol; 1991 Aug; 69 ( Pt 4)():235-41. PubMed ID: 1786994 [TBL] [Abstract][Full Text] [Related]
6. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. Mauël J; Ransijn A; Buchmüller-Rouiller Y J Leukoc Biol; 1991 Jan; 49(1):73-82. PubMed ID: 1845812 [TBL] [Abstract][Full Text] [Related]
7. Production of interleukin-1 and tumor necrosis factor by bone marrow-derived macrophages: effect of cisplatin and lipopolysaccharide. Suresh A; Sodhi A Immunol Lett; 1991 Sep; 30(1):93-100. PubMed ID: 1959946 [TBL] [Abstract][Full Text] [Related]
8. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. Chan J; Xing Y; Magliozzo RS; Bloom BR J Exp Med; 1992 Apr; 175(4):1111-22. PubMed ID: 1552282 [TBL] [Abstract][Full Text] [Related]
9. Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis. Akaki T; Tomioka H; Shimizu T; Dekio S; Sato K Clin Exp Immunol; 2000 Aug; 121(2):302-10. PubMed ID: 10931146 [TBL] [Abstract][Full Text] [Related]
10. L-arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide. Hauschildt S; Bassenge E; Bessler W; Busse R; Mülsch A Immunology; 1990 Jul; 70(3):332-7. PubMed ID: 1974243 [TBL] [Abstract][Full Text] [Related]
11. Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites. Tomioka H; Sato K; Sano C; Akaki T; Shimizu T; Kajitani H; Saito H Clin Exp Immunol; 1997 Aug; 109(2):248-54. PubMed ID: 9276519 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Burnette-Curley D; Cabral GA Proc Soc Exp Biol Med; 1995 Oct; 210(1):64-76. PubMed ID: 7675800 [TBL] [Abstract][Full Text] [Related]
13. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice. Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845 [TBL] [Abstract][Full Text] [Related]
14. In vitro activation of murine bone marrow-derived macrophages with cisplatin and mitomycin-C. Suresh A; Sodhi A; Singh SM; Basu S Int J Immunopharmacol; 1991; 13(2-3):189-95. PubMed ID: 1906438 [TBL] [Abstract][Full Text] [Related]
15. Effect of tumor cells on the activation of murine lymphocytes and macrophages by cisplatin and FK565. Kumar A; Singh SM; Sodhi A Neoplasma; 1997; 44(5):319-23. PubMed ID: 9473793 [TBL] [Abstract][Full Text] [Related]
16. Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. Higuchi M; Higashi N; Taki H; Osawa T J Immunol; 1990 Feb; 144(4):1425-31. PubMed ID: 2303713 [TBL] [Abstract][Full Text] [Related]
17. The relationship between L-arginine-dependent nitric oxide synthesis, nitrite release and dinitrosyl-iron complex formation by activated macrophages. Vanin AF; Mordvintcev PI; Hauschildt S; Mülsch A Biochim Biophys Acta; 1993 May; 1177(1):37-42. PubMed ID: 8387340 [TBL] [Abstract][Full Text] [Related]
18. Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. Biswas SK; Sodhi A; Paul S Nitric Oxide; 2001 Dec; 5(6):566-79. PubMed ID: 11730364 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Flesch IE; Kaufmann SH Infect Immun; 1991 Sep; 59(9):3213-8. PubMed ID: 1908829 [TBL] [Abstract][Full Text] [Related]
20. Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Parajuli P; Singh SM; Kumar A Int J Immunopharmacol; 1995 Jan; 17(1):1-7. PubMed ID: 7782149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]